Aleman Roxanne T, Rauch Julia, Desai Janvi, Chaiban Joumana T
Internal Medicine, Advocate Christ Medical Center, Oak Lawn, USA.
Internal Medicine, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, USA.
Cureus. 2022 Jul 14;14(7):e26845. doi: 10.7759/cureus.26845. eCollection 2022 Jul.
The unpredictability of the coronavirus disease 2019 (COVID-19) pandemic has created an ongoing global healthcare crisis. Implementation of a mass vaccination program to accelerate disease control remains in progress. Although injection site soreness, fatigue, and fever are the most common adverse reactions reported after a COVID-19 vaccination, ipsilateral lymph node enlargement has increasingly been observed. In patients undergoing routine screening and surveillance for breast cancer, interpreting lymphadenopathy (LAP) is challenging in the setting of a recent COVID-19 vaccination. With a growing proportion of the population receiving the vaccine, a multifaceted approach is necessary to avoid unnecessary and costly workup. In this comprehensive review, we summarize the existing literature on COVID-19 vaccine-associated LAP in breast imaging patients.
2019冠状病毒病（COVID-19）大流行的不可预测性引发了一场持续的全球医疗危机。大规模疫苗接种计划的实施正在进行中，以加速疾病控制。虽然注射部位疼痛、疲劳和发热是COVID-19疫苗接种后报告的最常见不良反应，但同侧淋巴结肿大的情况也越来越多地被观察到。在接受乳腺癌常规筛查和监测的患者中，在近期接种COVID-19疫苗的情况下，解读淋巴结病（LAP）具有挑战性。随着越来越多的人口接种疫苗，需要采取多方面的方法来避免不必要的昂贵检查。在这篇综述中，我们总结了关于乳腺癌成像患者中与COVID-19疫苗相关的LAP的现有文献。
